4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 42, Issue 3, Pages 737-748
Publisher
Wiley
Online
2011-12-05
DOI
10.1002/eji.201141920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
- (2010) H. E. Kohrt et al. BLOOD
- The clinical application of monoclonal antibodies in chronic lymphocytic leukemia
- (2010) S. M. Jaglowski et al. BLOOD
- Glucocorticoid-Induced TNFR-Related (GITR) Protein and Its Ligand in Antitumor Immunity: Functional Role and Therapeutic Modulation
- (2010) Theresa Placke et al. Clinical & Developmental Immunology
- Rituximab
- (2010) Gillian M. Keating DRUGS
- CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction
- (2010) Zhe Shao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Evolution of anti- CD20 monoclonal antibody therapeutics in oncology
- (2010) Ezogelin Oflazoglu et al. mAbs
- Rituximab: Mechanism of Action
- (2010) George J. Weiner SEMINARS IN HEMATOLOGY
- CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells
- (2009) T. Baessler et al. BLOOD
- Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein Ligand Subverts Immunosurveillance of Acute Myeloid Leukemia in Humans
- (2009) T. Baessler et al. CANCER RESEARCH
- Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
- (2009) Wen-Kai Weng et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma
- (2009) J A Woyach et al. LEUKEMIA
- Neutralization of tumor-derived soluble Glucocorticoid-Induced TNFR-Related Protein ligand increases NK cell anti-tumor reactivity
- (2008) K. M. Baltz et al. BLOOD
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodies
- (2008) W. Lin et al. BLOOD
- Lysis of cancer cells by autologous T cells in breast cancer pleural effusates treated with anti-EpCAM BiTE antibody MT110
- (2008) Juliane Witthauer et al. BREAST CANCER RESEARCH AND TREATMENT
- The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
- (2008) David H. Lynch IMMUNOLOGICAL REVIEWS
- Glucocorticoid-induced Tumor Necrosis Factor Receptor Negatively Regulates Activation of Human Primary Natural Killer (NK) Cells by Blocking Proliferative Signals and Increasing NK Cell Apoptosis
- (2008) Baoying Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
- (2008) James O. McNamara et al. JOURNAL OF CLINICAL INVESTIGATION
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation